DENVAX(R)

DENDRITIC CELL THERAPY

Customized Cell-based Cancer Immunotherapy 

 

 

Serving since 2004

  

PERSONALIZED CANCER TREATMENT PLAN 

DENVAX IS NOT A DRUG OR STEM CELL THERAPY

IT IS MADE BY PATIENT'S OWN WHITE BLOOD CELLS COLLECTED FROM PERIPHERAL BLOOD 

THE DENVAX LAB
J-3, Sector 41
Noida, UP 201303
India

info@dendriticcellresearch.com

Like us:TwitterFacebook

  • HOME
    • DISCOVERY OF DENDRITIC CELLS
  • MALAYSIA
  • UNITED ARAB EMIRATES
  • DENVAX
  • DENVAX PROTOCOL
  • DENVAX FAQs
  • PATIENT INFORMATION
  • SUCCESS STORIES
  • PUBLICATIONS
  • CLINICAL TRIAL RESULT
  • ABOUT US
  • CONTACT US
    • ANTAH HEALTHCARE, MALAYSIA

news: DENVAX-O ( for ovarian cancers) phase III/IV trial  approved by ICMR trial registry (India)                                                 



 

 

DENDRITIC CELLS (DC) are the key ANTIGEN PRESENTING CELLS (APC) of the immune system.

They are the cells that INITIATE, DIRECT and REGULATE the immune responses.

 

 

 

 

DENVAX

The DENVAX is dendritic cell based cancer immunotherapy for solid cancers in various stages of the disease. It is autologous treatment, which involves patient's own mononuclear cells transformed into cancer-specific dendritic cells.

Designed to be specific, DENVAX targets only the cancer cells without harming the healthy ones. It is safe and effective and works best to prevent relapse and recurrences, the major cause of mortality and morbidity.

DENVAX helps in correcting the failed immune surveillance and teaches the immune system to recognize and kill cancer cells.

Why do cancers relapse?

A cancer relapse occurs because in spite of the best efforts to get rid of cancer, some cancer cells are left behind. These cancer cells remain dormant for a period of time, but eventually they continue to multiply resulting in the recurrence or relapse.

What is the best way to treat relapse?

Cancer treatment modalities like surgical resection, chemotherapy and/or radiation are mostly ineffective in controlling the micrometastasis. Micrometastases are single tumor cells or clusters of cells shed by solid cancers and disseminated in various organs of the body. Micrometastases have a pronounced clinical effect, are hard to detect and can be the starting point of recurrence of cancer.

DENVAX targets the micrometastais and destroys the disseminated cancer cells, thereby preventing its development, slowing the spread of cancer and improving the life expectancy.

  A dendritic cell passes information to T cell
DISCLAIMER
Dendritic cell therapy in the form of DenvaxTM is given to patients after explaining the protocol in detail. They are made aware about its additional (adjuvant) role in cancer treatment and prevention of relapse clearly. In no way it is a substitute to standard cancer treatment. A written consent is also taken before initiating the cancer treatment process. It mentions that the therapy may be beneficial or it may have no benefits.

ICT Mission

  • To individualize each cancer treatment plan and provide comprehensive treatment in cancer to help them overcome their disease;
  • To help patients achieve complete remission and prevent relapses by initiating cancer treatment at the right time, when tumor load is minimal;
  • To provide the highest quality of cell therapy at lowest prices, to make the cancer treatment affordable to a large number of patients.

INDIA OFFICE

Denvax Clinics

 

 

 Call Toll Free Number 18001231132

 

DELHI

18, Poorvi Marg

Vasant Vihar

 

Phone 011-41060168

 

MUMBAI

Mangaljyot Society

Near Signal Crossing

Juhu Lane

 

Phone 022-66952646

 

 

AHMEDABAD

Shop G1, Span Trading Center

Ashram Road, Paldi

Phone 079-40396660

 

KOLKATTA

G 8, Shri Ram Nagar Complex

VIP Road, Area Code 700052

033-65555444

 

HYDERABAD

5, Ground Floor, MGR Estate

Dwarkapuri Colony, Panjagutta - 500082

040-48561830

 

CHENNAI

G 19, Elcanso Complex

10, Casa Major Road, Egmore

044-42076812

 

 

MALAYSIA OFFICE 

 

+60 3 27282267

+60 3 27282268

 

 

UAE OFFICE

 

+971 6 5012010

 

 

 

 

 

 

  Copyright Institute of Cellular Therapies Pvt. Ltd.

All rights reserved.

Last updated on 12 January 2019

 

 

 

CLINICS MANAGED BY OPTIMUM THERAPEUTICS COMPANY

 

THE DENVAX LAB
J-3, Sector 41
Noida, UP 201303
India

info@dendriticcellresearch.com

Like us:TwitterFacebook